DZ315A1 - Powder based on bacampicillin acid addition salt micro-encaspsule and pharmaceutical composition containing it. - Google Patents

Powder based on bacampicillin acid addition salt micro-encaspsule and pharmaceutical composition containing it.

Info

Publication number
DZ315A1
DZ315A1 DZ816254A DZ816254A DZ315A1 DZ 315 A1 DZ315 A1 DZ 315A1 DZ 816254 A DZ816254 A DZ 816254A DZ 816254 A DZ816254 A DZ 816254A DZ 315 A1 DZ315 A1 DZ 315A1
Authority
DZ
Algeria
Prior art keywords
encaspsule
pharmaceutical composition
composition containing
acid addition
addition salt
Prior art date
Application number
DZ816254A
Other languages
French (fr)
Inventor
Morgan Lee Beatty
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ315A1 publication Critical patent/DZ315A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DZ816254A 1980-08-22 1981-07-08 Powder based on bacampicillin acid addition salt micro-encaspsule and pharmaceutical composition containing it. DZ315A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/180,537 US4321253A (en) 1980-08-22 1980-08-22 Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Publications (1)

Publication Number Publication Date
DZ315A1 true DZ315A1 (en) 2004-09-13

Family

ID=22660812

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ816254A DZ315A1 (en) 1980-08-22 1981-07-08 Powder based on bacampicillin acid addition salt micro-encaspsule and pharmaceutical composition containing it.

Country Status (41)

Country Link
US (1) US4321253A (en)
JP (1) JPS5775986A (en)
KR (1) KR860000513B1 (en)
AR (1) AR227201A1 (en)
AT (1) AT370994B (en)
AU (1) AU529965B2 (en)
BE (1) BE890028A (en)
BG (1) BG42000A3 (en)
CA (1) CA1137414A (en)
CH (1) CH650674A5 (en)
CS (1) CS225845B2 (en)
DD (1) DD201644A5 (en)
DE (1) DE3132614C2 (en)
DK (1) DK158971C (en)
DZ (1) DZ315A1 (en)
ES (1) ES8303091A1 (en)
FI (1) FI72647C (en)
FR (1) FR2488798A1 (en)
GB (1) GB2082539B (en)
GR (1) GR74983B (en)
HK (1) HK43786A (en)
HU (1) HU188679B (en)
IE (1) IE51506B1 (en)
IL (1) IL63617A (en)
IN (1) IN156538B (en)
IT (1) IT1138161B (en)
KE (1) KE3626A (en)
LU (1) LU83572A1 (en)
MX (1) MX5731A (en)
MY (1) MY8600597A (en)
NL (1) NL191978C (en)
NO (1) NO154821C (en)
NZ (1) NZ198106A (en)
PH (1) PH17125A (en)
PL (1) PL232141A1 (en)
PT (1) PT73555B (en)
RO (1) RO82679B (en)
SE (1) SE448819B (en)
SU (1) SU1364226A3 (en)
YU (1) YU43985B (en)
ZA (1) ZA815793B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
SE8103843L (en) * 1981-06-18 1982-12-19 Astra Laekemedel Ab PHARMACEUTICAL MIXTURE
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (en) * 1982-06-24 1982-06-24 Astra Laekemedel Ab PHARMACEUTICAL MIXTURE
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
EP0111560A4 (en) * 1982-06-14 1987-02-03 Key Pharma Sustained release aspirin.
DE3382392D1 (en) * 1982-07-09 1991-10-02 Key Pharma DOSAGE FOR THE CONTINUOUS ADMINISTRATION OF CHINIDINE.
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE8405611D0 (en) * 1984-11-09 1984-11-09 Astra Laekemedel Ab PROCESS FOR STABILIZATION OF BACAMPICILLIN HYDROCHLORIDE
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5599557A (en) * 1992-04-30 1997-02-04 Schering Corporation Stable hydrated cephalosporin dry powder for oral suspension formulation
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
IN191482B (en) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
JP4711478B2 (en) * 1999-08-13 2011-06-29 旭化成ケミカルズ株式会社 Taste masked drug
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
SK8562002A3 (en) 1999-12-23 2003-10-07 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
PT1276470E (en) 2000-04-20 2007-08-13 Novartis Ag Taste masking coating composition
US20040142475A1 (en) * 2000-06-02 2004-07-22 Barman Shikha P. Delivery systems for bioactive agents
FR2822834B1 (en) * 2001-04-02 2005-02-25 Flamel Tech Sa COLLOIDAL SUSPENSION OF NANOPARTICLES BASED ON AMPHIPHILIC COPOLYMERS FOR VECTORIZATION OF ACTIVE INGREDIENTS AND THEIR METHOD OF PREPARATION
US20030096791A1 (en) * 2001-05-31 2003-05-22 Cima Labs Inc. Taste masking of highly water-soluble drugs
KR20030015655A (en) * 2001-08-17 2003-02-25 한미약품공업 주식회사 Crystalline acid-added salt of an indane-based compound for increasing oral absorption of an anti-cancer agent, preparation thereof and pharmaceutical composition comprising same
FR2830447B1 (en) * 2001-10-09 2004-04-16 Flamel Tech Sa MICROPARTICULAR ORAL GALENIC FORM FOR DELAYED AND CONTROLLED RELEASE OF PHARMACEUTICAL ACTIVE INGREDIENTS
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
AU2003246791A1 (en) * 2002-04-09 2003-10-20 Flamel Technologies Oral suspension of amoxicillin capsules
DE60325709D1 (en) 2002-04-09 2009-02-26 Flamel Tech Sa ORAL AQUEOUS SUSPENSION CONTAINING MICRO CAPSULES FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES
FR2842736B1 (en) 2002-07-26 2005-07-22 Flamel Tech Sa ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF A PLURALITY OF MICROCAPSULES FOR PROLONGED RELEASE OF LOW SOLUBLE ACTIVE (S) PRINCIPLE (S)
FR2842735B1 (en) * 2002-07-26 2006-01-06 Flamel Tech Sa MODIFIED RELEASE MICROCAPSULES OF LOW SOLUBLE ACTIVE PRINCIPLES FOR PER OS ADMINISTRATION
FR2843117B1 (en) * 2002-07-30 2004-10-15 Flamel Tech Sa POLYAMINOACIDS FUNCTIONALIZED BY AT LEAST ONE HYDROPHOBIC GROUP AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2860516B1 (en) * 2003-10-03 2006-01-13 Flamel Tech Sa TELECHELIC HOMOPOLYAMINOACIDES FUNCTIONALIZED BY HYDROPHOBIC GROUPS AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS
FR2862536B1 (en) * 2003-11-21 2007-11-23 Flamel Tech Sa PHARMACEUTICAL FORMULATIONS FOR THE PROLONGED DELIVERY OF ACTIVE (S) PRINCIPLE (S) AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
FR2885526B1 (en) * 2005-05-13 2007-07-27 Flamel Technologies Sa ORAL MEDICINE BASED ON PROTON PUMP INHIBITOR
CN108601796B (en) * 2015-10-13 2020-03-03 技术防卫株式会社 Gastrointestinal mucosa protective composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
ZA718014B (en) 1970-12-23 1972-08-30 Beecham Group Ltd Pharmaceutical formulations
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
GB1479655A (en) 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS5840529B2 (en) * 1975-09-29 1983-09-06 明治製菓株式会社 Keikouyou Seizaino Seiho
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
ZA793935B (en) * 1978-08-04 1980-07-30 Beecham Group Ltd Powders
JPS57105316A (en) * 1980-12-23 1982-06-30 Hitachi Cable Ltd Method of fitting heat-shrinkable tube

Also Published As

Publication number Publication date
ZA815793B (en) 1982-08-25
AU529965B2 (en) 1983-06-30
ES504905A0 (en) 1983-02-01
AR227201A1 (en) 1982-09-30
ES8303091A1 (en) 1983-02-01
KE3626A (en) 1986-05-16
YU43985B (en) 1990-02-28
SE448819B (en) 1987-03-23
KR830005850A (en) 1983-09-14
IE811911L (en) 1982-02-22
NZ198106A (en) 1983-12-16
IN156538B (en) 1985-08-31
MX5731A (en) 1993-11-01
SE8104974L (en) 1982-02-23
DE3132614A1 (en) 1982-05-19
JPH0248525B2 (en) 1990-10-25
BE890028A (en) 1982-02-22
CS225845B2 (en) 1984-02-13
GR74983B (en) 1984-07-12
GB2082539B (en) 1984-01-18
FI72647C (en) 1987-07-10
DE3132614C2 (en) 1985-08-22
FI812574L (en) 1982-02-23
LU83572A1 (en) 1982-04-14
AT370994B (en) 1983-05-25
DK372181A (en) 1982-02-23
FR2488798B1 (en) 1985-01-11
CH650674A5 (en) 1985-08-15
NO154821B (en) 1986-09-22
PT73555B (en) 1983-07-14
IE51506B1 (en) 1987-01-07
AU7441681A (en) 1982-04-01
SU1364226A3 (en) 1987-12-30
FR2488798A1 (en) 1982-02-26
BG42000A3 (en) 1987-09-15
PL232141A1 (en) 1982-03-15
NL8103902A (en) 1982-03-16
RO82679A (en) 1984-05-23
NO812827L (en) 1982-02-23
FI72647B (en) 1987-03-31
HU188679B (en) 1986-05-28
DK158971C (en) 1991-01-07
MY8600597A (en) 1986-12-31
IL63617A0 (en) 1981-11-30
PT73555A (en) 1981-09-01
ATA362781A (en) 1982-10-15
CA1137414A (en) 1982-12-14
RO82679B (en) 1984-07-30
HK43786A (en) 1986-06-20
IL63617A (en) 1984-11-30
GB2082539A (en) 1982-03-10
NL191978C (en) 1996-12-03
US4321253A (en) 1982-03-23
IT8123587A0 (en) 1981-08-20
NL191978B (en) 1996-08-01
DK158971B (en) 1990-08-13
YU201781A (en) 1984-04-30
KR860000513B1 (en) 1986-05-02
NO154821C (en) 1987-01-07
PH17125A (en) 1984-06-01
IT1138161B (en) 1986-09-17
DD201644A5 (en) 1983-08-03
JPS5775986A (en) 1982-05-12

Similar Documents

Publication Publication Date Title
DZ315A1 (en) Powder based on bacampicillin acid addition salt micro-encaspsule and pharmaceutical composition containing it.
FR2586562B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A-METHYLHISTAMINE
FR2582513B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE
MA21182A1 (en) ESTER 2,3,5,6-TETRAFLUOROBENZYLIC ACID (+) 1R-TRANS-2,2-DIMEGHYL-3- (2,2 DICHLOROVINYL) -CYCLOPROPANE-CARBOXYLIQUE, ITS PREPARATION PROCESS AND INSECTICIDE COMPOSITION CONTAINING IT.
FR2602974B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICOTINE OR DERIVATIVES THEREOF
BE860794A (en) POWDER OR GRANULES CONTAINING SORBIC ACID
FR2505835B1 (en) NOVEL 1,2-DIAMINOCYCLOBUTENE-3,4-DIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
IT8621358A0 (en) PHARMACEUTICAL COMPOSITION ANALGESIC ADAPTIVITY.
MC1915A1 (en) Processes for the preparation of 2 ', 3'-dideoxynucleosides and pharmaceutical formulations containing them
FR2411839B1 (en) CEPHALOSPORANIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
BE880065A (en) NOVEL SPIRO-POLYCYCLO-IMIDAZOLIDINEDIONES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
BE879472A (en) PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DIHYDRO-3-OXO-2-QUINOXALINES
FR2608921B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING RANITIDINE
FR2490491B1 (en) ANALGESIC PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT 3-AMINO-2-HYDROXY-4 PHENYLBUTANOIC ACID AND DERIVATIVES THEREOF AND APPLICATION
FR2446819B1 (en) 6-ALKYL DERIVATIVES OF 1,2-DIHYDRO-2-OXONICOTINIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2450814B1 (en) 24,24-DIFLUORO-25-HYDROXYCHOLECALCIFEROL AND PHARMACEUTICAL COMPOSITION CONTAINING THIS PRODUCT
FR2609392B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PYRANOQUINOLEINS
FR2509611B1 (en) NOVEL ACID AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
BE864027A (en) PROCESS FOR THE PREPARATION OF ALPHA-2,5,9-TRIMETHYLBENZO- (B) -THIENO- (2,3, F) -MORPHANE, PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITION CONTAINING IT
PT77767A (en) PROCESS FOR THE PREPARATION OF 3 ', 5'-DIARABINOSIDES AND PHARMACEUTICAL COMPOSITI-ONS CONTAINING THEM
FR2512342B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-INFLAMMATORY MEDICINAL PRODUCT AND RANITIDINE OR A SALT THEREOF
DZ1748A1 (en) Lysine salt of 6-chloro-5-fluoro-3- (2-thenoyl) -2-oxindole-1-carboxamide and pharmaceutical composition containing it.
PT87828A (en) PROCEDE DE PREPARATION D'HERBICIDES DE TYPE SULFONYLUREE ET DE COMPOSITIONS HERBICIDES LES CONTENANT
IT8222593A0 (en) PROCEDURE FOR PREPARATION OF PHENMEDIPHAM HERBICIDE.